% Expired Patents = 100.0

Forward Citations = 79

Loading Chart...

4 inventors (with patents filed for the assignee):

Hosheng Tu (4 out of 153 patents)

Yu-An Chang (4 out of 6 patents)

Hun-Chi Lin (3 out of 5 patents)

4. Daniel H Duff (1 out of 10 patents)

4 patents: Sort by Forward Citations

1. 7470245 - Extracorporeal pathogen reduction system (2008-12-30),

2. 7314460 - Extracorporeal pathogen reduction system (2008-01-01),

3. 6969367 - Extracorporeal pathogen reduction system (2005-11-29),

4. 6960178 - Apparatus for enhanced plasmapheresis and methods thereof (2005-11-01),

Company Overview

Xepmed, Inc. is a leading biotechnology company specializing in the development of innovative medical technologies for personalized medicine. With a focus on precision diagnostics and targeted therapeutics, Xepmed is committed to improving patient outcomes and revolutionizing healthcare. Our cutting-edge research and state-of-the-art solutions are transforming the way diseases are diagnosed and treated, ultimately leading to a healthier and more sustainable future.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#458 in Los Angeles, CA

#14,051 in California

#60,641 in US

Los Angeles, CA, United States of America

Xepmed, Inc.

Forward Citations = 79

4 inventors:

Hosheng Tu (4 out of 153 patents)

Yu-An Chang (4 out of 6 patents)

Hun-Chi Lin (3 out of 5 patents)

4. Daniel H Duff (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xepmed, Inc.. Retrieved from https://idiyas.com/company/xepmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]